Follow-Up After Pulmonary Valve Replacement in Adults With Tetralogy of Fallot
|
|
- Roy McDowell
- 5 years ago
- Views:
Transcription
1 Journal of the American College of Cardiology Vol. 56, No. 18, by the American College of Cardiology Foundation ISSN /$36.00 Published by Elsevier Inc. doi: /j.jacc Adult Congenital Heart Disease Follow-Up After Pulmonary Valve Replacement in Adults With Tetralogy of Fallot Association Between QRS Duration and Outcome Roderick W. C. Scherptong, MD,* Mark G. Hazekamp, MD, PHD, Barbara J. M. Mulder, MD, PHD, Olivier Wijers, MSC,* Cees A. Swenne, PHD,* Ernst E. van der Wall, MD, PHD,* Martin J. Schalij, MD, PHD,* Hubert W. Vliegen, MD, PHD* Leiden, Amsterdam, and Utrecht, the Netherlands Objectives Background Methods Results Conclusions The aim of this study was to analyze whether QRS duration, before and after pulmonary valve replacement (PVR), is related to long-term outcome in patients with tetralogy of Fallot (TOF). Key factors that determine outcome after PVR in adult TOF patients are largely unknown. Recognition of such factors assists the identification of patients at increased risk of adverse events. Adults who previously underwent total correction for TOF (n 90; age years) and required PVR for pulmonary regurgitation were included. The QRS duration was measured pre-operatively and 6 months after PVR. The post-operative changes in QRS duration were calculated. Adverse events (death, re-pvr, ventricular tachycardia, and symptomatic heart failure) were noted during follow-up. During years of follow-up, 13 adverse events occurred. The 5-year event-free survival rate was 76% for patients with a pre-operative QRS duration 180 ms and 90% in patients with a QRS duration 180 ms (p 0.037). For patients with a post-operative QRS duration 180 ms, 5-year event-free survival was 71%, whereas it was 91% for patients with a post-operative QRS duration 180 ms (p 0.004). After multivariate correction, a post-operative QRS duration 180 ms (hazard ratio: 3.685, 95% confidence interval: to , p 0.05) and the absence of a reduction in QRS duration post-pvr (hazard ratio: 6.767, 95% confidence interval: to , p 0.01), was significantly associated with adverse outcome. Severe QRS prolongation, before or after PVR, and the absence of a reduction in QRS duration after PVR, are major determinants of adverse outcome during long-term follow-up of patients with TOF. (J Am Coll Cardiol 2010;56: ) 2010 by the American College of Cardiology Foundation Progressive pulmonary regurgitation (PR) is a common complication after total surgical correction of tetralogy of Fallot (TOF) (1). Long-standing PR leads to right ventricular (RV) dilation, which in turn causes RV dysfunction and reduced exercise tolerance (2,3). Pulmonary valve replacement (PVR) provides an adequate surgical therapy for PR as it leads to improvement of RV function and the patient s From the *Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands; Department of Cardiothoracic Surgery, Amsterdam Medical Center, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam Medical Center, Amsterdam, the Netherlands; and the Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands. Dr. Scherptong is supported by an unrestricted educational grant from Actelion Pharmaceuticals Nederland BV. Dr. Schalij receives research grants from Biotronik, Medtronic, and Boston Scientific. All other authors have reported that they have no relationships to disclose. Manuscript received December 31, 2009; revised manuscript received March 10, 2010, accepted April 13, functional class (4). Numerous studies have indicated the beneficial effects of PVR in terms of improvement of RV volume and ejection fraction shortly after PVR (5 7). In addition, it was demonstrated that RV depolarization and repolarization characteristics improve after PVR, partly in response to the reduction in RV volumes (8,9). Specifically, QRS duration, which is strongly associated with RV function and prognosis in TOF (10), tends to reduce after PVR (8). In addition, it is known that TOF patients with severely prolonged QRS duration ( 180 ms) are at risk for adverse events (11). Nevertheless, it is unclear whether an association exists between, on the one hand, pre-pvr QRS duration and post-pvr changes in QRS duration and, on the other hand, long-term outcome after PVR. Consequently, the clinical relevance of pre- and post-pvr QRS duration, and of changes in QRS duration after PVR, is presently unknown. The current study aimed to assess how pre-operative QRS duration and post-
2 JACC Vol. 56, No. 18, 2010 October 26, 2010: Scherptong et al. Long-Term Outcome After PVR in TOF Patients 1487 operative changes in QRS duration are related to outcome during long-term follow-up after PVR in TOF patients. Methods Study population. In a prospective, multicenter cohort study, adult patients after prior total repair for TOF, who had undergone a PVR for PR, were followed up (12,13). In all patients, primary surgical repair was performed during childhood. The indications for PVR were moderate to severe PR in combination with RV dilation and impaired New York Heart Association (NYHA) functional class (4). A standard 12-lead electrocardiogram (ECG) was obtained immediately before and 6 months after PVR. If an ECG was not available at 1 of the time points, patients were excluded from further analysis. All patients were followed up annually at the out-patient clinic, and the occurrence of adverse events was noted during follow-up after PVR. Adverse events were defined as death due to any cause, reoperation for recurrent pulmonary regurgitation, symptomatic heart failure, and ventricular arrhythmias. Surgical procedures. The PVR was performed through median sternotomy. After release of adhesions, total cardiopulmonary bypass was started. A cryopreserved pulmonary homograft was implanted, usually on beating heart. If necessary, small residual ventricular septal defects were suture closed, and right ventricular outflow tract (RVOT) reconstruction was performed as described previously (12). In addition, when pre-operative assessment revealed significant tricuspid regurgitation, tricuspid annuloplasty was performed (14). Electrocardiographic analysis. Electrocardiograms were stored digitally and exported from the ECG database management system for off-line analysis with the MATLAB-based (The MathWorks, Natick, Massachusetts) computer program LEADS (Leiden, the Netherlands). Details about the calculation methods used in LEADS have been reported previously (15). The software averages a digitized version of the standard 12-lead surface ECG into a representative single-beat ECG in which all 12 leads are superimposed. The software is equipped with a cross-hair editor interface that allows magnification of the ECG, and thereby facilitates accurate measurement of QRS duration according to the Minnesota criteria for population-based ECG studies (8). All ECGs were analyzed by a single observer blinded to the patient s clinical status and operation results. The cut-off for severely prolonged QRS duration was set at 180 ms (10,11). Statistical analysis. The SPSS version software (SPSS, Inc., Chicago, Illinois) was used for statistical analysis. GraphPad Prism 4.00 for Windows (GraphPad Software, La Jolla, California) was used to obtain life tables and corresponding Kaplan-Meier survival curves. First, pre- and post-operative QRS duration and NYHA functional class were compared using a paired t test. Second, the association between QRS duration and the occurrence of adverse events during postoperative follow-up was assessed using Cox s proportional hazards regression analysis. Univariate hazard ratios (HR) were calculated with corresponding 95% confidence interval (CI) for the following variables: 1) pre- and postoperative QRS duration as a continuous variable, in ms; 2) preand post-operative QRS duration as a categorical variable, 180 or 180 ms; 3) changes in QRS duration, from pre- to post-operative, as a continuous variable, in ms; and 4) changes in QRS duration, from pre- to post-operative, as a categorical variable, expressed as the presence or the absence of reduction in QRS duration. Afterward, the HRs were adjusted for age at PVR (below or above the median age of 30 years) and the presence of concomitant procedures during PVR, to obtain the multivariate HRs. Third, the annualized event rates were assessed in patient subgroups on the basis of the pre- and post-operative QRS durations ( 180 or 180 ms) in addition to the postoperative changes in QRS duration (reduction or no reduction). The number of observed events was normalized to 100 patient-years in each subgroup to facilitate comparison between groups. Afterward, the 95% CI of the observed event rate was calculated, and the difference in event rate was compared to the overall event rate by assuming that the number of observed events has a Poisson distribution. Finally, to visualize the difference in event-free survival between different QRS duration patient categories, Kaplan- Meier curves were drawn and log-rank statistics were calculated for the following 3 patient subgroups: 1) preoperative QRS duration 180 or 180 ms; 2) postoperative QRS duration 180 or 180 ms; and 3) changes in QRS duration, expressed as the presence or absence of a post-operative reduction in QRS duration. Separate Kaplan-Meier curves were obtained in which death, symptomatic heart failure, and ventricular arrhythmias were included as an end point and re-pvr was excluded. Where appropriate, data are reported as mean SD, n (%), or as HR (95% CI). All p values 0.05 were considered statistically significant. Results Abbreviations and Acronyms CI confidence interval ECG electrocardiogram HR hazard ratio NYHA New York Heart Association PA pulmonary artery PR pulmonary regurgitation PVR pulmonary valve replacement RV right ventricular RVOT right ventricular outflow tract TOF tetralogy of Fallot Ninety-nine consecutive corrected TOF patients who underwent PVR at adulthood were considered for the study. Nine patients were excluded because of missing ECGs, and the remaining 90 patients were all included in the study (Table 1). The PVR was performed at an age of years, and pre-operative NYHA functional
3 1488 Scherptong et al. JACC Vol. 56, No. 18, 2010 Long-Term Outcome After PVR in TOF Patients October 26, 2010: Patient Population (n 90) Table 1 Patient Population (n 90) Sex Male 53 (59) Female 37 (41) Characteristics of initial repair Age, yrs Transannular patch 62 (69) RV patch 9 (10) RV to PA conduit 5 (6) No patch 14 (16) Characteristics of PVR Pre-operative NYHA functional class Age, yrs Homograft diameter, mm Concomitant procedures Patients with concomitant procedures 42 (47) Ventricular septal defect closure 2 (2) RVOT reconstruction 27 (30) Tricuspid valvuloplasty 17 (19) QRS duration Pre-operative, ms Changes from pre- to post-operative, ms 4 17* Post-operative, ms Values are n (%) or mean SD. *p for the difference between pre- and post-operative QRS duration. NYHA New York Heart Association; PA pulmonary artery; PVR pulmonary valve replacement; RV right ventricular; RVOT right ventricular outflow tract. class was The size of the implanted homografts was mm, and concomitant surgical procedures, mostly RVOT reconstructions, were required in 42 patients (47%) (Table 1). Clinical outcome. No patients were lost to follow-up. After PVR, NYHA functional class improved from to (p 0.001). During a mean follow-up duration of years (range 1.1 to 17.9 years), 13 adverse events occurred (Fig. 1A). The observed event-free follow-up was 100% at 1 year, 96% at 2 years, 89% at 5 years, and 78% at 10 years (Fig. 1B). During follow-up, 2 patients died after 1.4 and 8.5 years, respectively, of sudden cardiac death (first patient) and fast-progressive, therapy refractory heart failure (second patient). Re-PVR was performed in 5 patients, and ventricular tachycardia requiring implantation of an implantable cardioverter defibrillator occurred in 4 patients. Prediction of patient outcome using QRS duration. Before PVR, QRS duration was ms, which reduced 4 17 ms to ms 6 months after surgery (p 0.027) (Table 1). Pre-operative NYHA functional class was not associated with pre- or post-operative QRS duration or the postoperative changes in QRS duration (black bars in Fig. 2) and demonstrated to improve in all patient groups based on QRS duration (Fig. 2). However, in patients with a QRS duration 180 ms, either pre- or post-operative, a less prominent improvement in NYHA functional class was observed as compared to patients with a QRS duration 180 ms pre-operatively (p 0.002) or post-operatively (p 0.045). Both pre- and post-operative QRS durations, as well as post-operative change in QRS duration, were significantly associated with adverse outcome after PVR (Table 2). The crude HRs of pre- and post-operative QRS duration were and 1.026, respectively, per ms increase in QRS duration. This indicated that a longer QRS duration either pre- or post-operatively was associated with a higher incidence of adverse events. Furthermore, the change in QRS duration from pre-operatively to 6 months after PVR was also related to post-operative outcome. The crude HR for the occurrence of adverse events was per ms change in QRS duration, demonstrating that a post-operative reduction in QRS duration was associated with a lower incidence of adverse events during follow-up. After multivariate correction, pre- and post-operative QRS duration and postoperative changes in QRS duration remained significantly related to the incidence of adverse events. Specifically, a post-operative QRS duration 180 ms or the lack of a reduction in QRS duration post-operatively were strong A B Figure 1 Patient Population and Follow-Up Characteristics (A) Overview of the events that occurred during follow-up of the study population, and (B) the overall Kaplan-Meier survival curve of the patients. The numbers below signify patients at risk. HF heart failure; PAR patients at risk; PVR pulmonary valve replacement; VT ventricular tachycardia.
4 JACC Vol. 56, No. 18, 2010 October 26, 2010: Scherptong et al. Long-Term Outcome After PVR in TOF Patients 1489 QRS duration (n 44). On the contrary, a significantly higher event rate was observed among patients who did not demonstrate a reduction in QRS duration and had a QRS duration 180 ms, either pre-operatively or postoperatively. In those groups, the event rates were 20.6 events (95% CI: 2.5 to 74.5; p vs. the overall population) and 9.3 events (95% CI: 2.5 to 23.8; p vs. the overall population) per 100 patient-years (Table 3). The Kaplan-Meier survival curves (Fig. 3) confirmed that patients with significantly prolonged QRS duration ( 180 ms) demonstrated worse event-free survival as compared with that of patients with a QRS duration 180 ms. The observed 5-year event-free survival was 76% for patients with a preoperative QRS duration 180 ms as compared with 90% for patients with a QRS duration 180 ms (p 0.037) (Fig. 3A). The observed 5-year event-free survival was 71% for patients with a post-operative QRS duration 180 ms as compared with 91% for patients with a QRS duration 180 ms (p 0.003) (Fig. 3E). Furthermore, 5-year event-free survival of patients in whom no reduction in QRS duration was observed 6 months after PVR was worse as compared with that of patients who had a reduction in QRS duration after PVR. The observed difference in event-free survival between those 2 groups was 24.5% at 5 years (p 0.004) (Fig. 3C). Exclusion of re-pvr as an end point in the Kaplan-Meier survival curve demonstrated that event-free survival was 4.1% lower in patients with a pre-operative QRS duration 180 ms as compared to 180 ms, which was not statistically significant (p 0.61) (Fig. 3B). The Kaplan-Meier curve, in which the patient population was stratified according to post-operative QRS duration ( 180 or 180 ms) or post-operative changes in QRS duration (reduction or no reduction), was similar whether or not re-pvr was excluded as an end point (Figs. 3D and 3F). Figure 2 NYHA Functional Class and QRS Duration Mean pre-operative (solid bars) and post-operative (open bars) New York Heart Association (NYHA) functional class (y-axis) depicted in relation to (x-axis) (A) pre-operative QRS duration, (B) post-operative changes in QRS duration, and (C) QRS durations 6 months post-operative. predictors of adverse events, with multivariate HRs of and 6.767, respectively. To further explore the association between QRS duration and event-free survival after PVR, the study population was subdivided based on QRS duration (pre- and postoperative; 180 or 180 ms), and post-operative change in QRS duration (reduction or no reduction), which yielded 8 subgroups (Table 3). Subsequently, the annualized event rate, normalized to 100 patient-years, was calculated for the overall study population and for the 8 subgroups (Table 3). The overall event rate in the study population was 2.7 (95% CI: 1.4 to 4.6) per 100 patient-years. No events were observed among patients with a pre-operative QRS duration 180 ms who demonstrated a post-operative reduction in Discussion The main findings of this study were: 1) a QRS duration 180 ms, either pre- or post-operatively, or the lack of a reduction in QRS duration after PVR, was significantly associated with adverse outcome after PVR; and 2) the highest incidence of adverse events was observed among patients with a severely prolonged QRS duration either pre- or postoperatively, without a reduction in QRS duration after PVR. Progressive PR is one of the most common complications after total surgical repair of TOF. In response to the regurgitated volume, the RV dilates to overcome the increased loading conditions (1,16). Long-standing PR will eventually lead to dysfunction of the RV, and patients may experience reduced exercise tolerance (17). In such cases, PVR with a competent pulmonary valve provides a satisfactory solution, with excellent short-term results in terms of ventricular function and NYHA functional class (4,18). Although long-term results are also good for PVR, a substantial number of patients still have adverse events during follow-up (7). In the current study, event-free
5 1490 Scherptong et al. JACC Vol. 56, No. 18, 2010 Long-Term Outcome After PVR in TOF Patients October 26, 2010: Prediction Table 2 ofprediction Outcome Using of Outcome QRS Duration Using QRS Duration Univariate Multivariate* HR 95% CI HR 95% CI Pre-operative Pre-operative 180 ms Post-operative Post-operative 180 ms Change in QRS duration No reduction in QRS duration *In the multivariate model, the hazard ratio (HR) was adjusted for age (below or above the median of 30 years) and concomitant surgical procedures during pulmonary valve replacement. Hazard ratio per ms increase in QRS duration. p p Hazard ratio per ms change in QRS duration. CI confidence interval. survival was 76% after 10 years, which is similar to that of other studies in which long-term survival after PVR was reported (12,19). A number of factors that are important for post-pvr outcome have been identified. These mainly include post-operative homograft-related factors such as early recurrence of PR or pulmonary stenosis (12,20). Interestingly, in the study by Oosterhof et al. (12), which was a large follow-up study that consisted of 158 adult TOF patients who underwent PVR, neither the type of initial TOF correction nor the PVR surgical characteristics were predictive of outcome after PVR. In that study, RV volumes and ejection fraction, assessed pre-operatively with cardiovascular magnetic resonance imaging, were not predictive of post-pvr outcome. Although it is known that QRS duration is strongly associated with outcome in TOF patients (10), no studies on the clinical application of QRS duration for the assessment of post-pvr outcome are available. The current study demonstrates that pre-operative QRS duration is associated with post-operative outcome. Longer QRS duration was significantly associated with increased incidence of adverse outcome after PVR. Furthermore, severe QRS prolongation ( 180 ms) after PVR and the absence of a reduction in QRS duration demonstrated an even stronger association with post-operative outcome. As re-pvr has an indirect association with ventricular function (12), separate Kaplan-Meier survival curves were obtained in which re-pvr was excluded as an end point. That confirmed that QRS duration has a strong association with post-pvr outcome in patients with TOF. The association between prolonged QRS duration and patient outcome in TOF was first recognized by Gatzoulis et al. (10). In a study on 178 adults with a previous total repair for TOF, it was demonstrated that ventricular tachycardia was associated with QRS prolongation beyond 180 ms. In addition, it was shown that patients who had an enlarged RV had a longer QRS duration. The relation between RV enlargement and QRS duration was confirmed thereafter in study by Book et al. (21). They demonstrated that prolonged QRS duration ( 150 ms), had a positive predictive value of 92% for the detection of RV dilation on cardiovascular magnetic resonance imaging. Moreover, Neffke et al. (22) demonstrated that QRS duration was also correlated to RV mass. In addition to the relation between QRS duration and ventricular function, it was shown in a study Budts et al. (23) that lack of reduction in QRS duration during exercise is significantly related to reduced exercise capacity in adult TOF patients. Furthermore, previous studies have indicated reduction of QRS duration in response to PVR (8). This reduction in QRS duration was related to the reduction in RV end-diastolic volume, which demonstrated that PVR improved the electrophysiological characteristics of the RV. However, to date, it Observed Table 3 Annualized ObservedEvent Annualized Rate According Event RatetoAccording QRS Duration to QRS Duration n Patient-Years Events Events/ 100 Patient-Years 95% CI Overall Pre-operative QRS duration 180 ms PO QRS reduction NA 180 ms PO QRS reduction ms PO QRS reduction ms PO QRS reduction * PO QRS duration 180 ms PO QRS reduction ms PO QRS reduction ms PO QRS reduction ms PO QRS reduction *p versus the overall group. p versus the overall group. CI confidence interval; NA not applicable; PO post-operative.
6 JACC Vol. 56, No. 18, 2010 October 26, 2010: Scherptong et al. Long-Term Outcome After PVR in TOF Patients 1491 Figure 3 Kaplan-Meier Survival Curves and QRS Duration Kaplan-Meier survival curves for patient subgroups stratified by (A, B) before pulmonary valve replacement (PVR) QRS duration; (C, D) post-operative changes in QRS duration; and (E, F) 6-month post-operative QRS duration. Separate curves are provided in which re-pvr was excluded as an end point (B, D, F). The p values denote the result of the log-rank test. (A, B, E, F) QRS durations 180 ms are indicated by green lines; QRS durations 180 ms are indicated by blue lines. (C, D) QRS reductions are indicated by green lines; no QRS reductions are indicated by blue lines. remained to be investigated whether these changes in electrophysiological characteristics were of relevance in terms of clinical outcome. The current study demonstrates for the first time that severe QRS prolongation ( 180 ms) either before or after PVR, or the absence of a reduction in QRS duration after PVR, is associated with the increased incidence of adverse outcome during long-term follow-up. It could be postulated that the patients who lack improvement in QRS duration have a poorer RV condition and thus exhibit a higher risk for adverse events as compared with patients who improve in QRS duration after PVR. Analogous with this, the observation that longer QRS duration before PVR was associated with increased incidence of adverse events after PVR may also be related to a more deteriorated RV condition already before PVR. That no events were observed in patients with a QRS duration 180 ms who demonstrated improvement of QRS duration after PVR may reflect the other end of the same pathophysiological spectrum. Study limitations. As with most studies on patients with congenital heart disease, a limitation of the current study is the relatively small number of patients. Therefore, a comprehensive multivariate Cox s regression analysis, in which
7 1492 Scherptong et al. JACC Vol. 56, No. 18, 2010 Long-Term Outcome After PVR in TOF Patients October 26, 2010: the HRs are adjusted for all possible confounders, could not be obtained. Furthermore, the subgroup analysis based on before and after PVR QRS duration and changes after PVR in QRS duration would benefit from a larger sample size, as that increases the precision of the event rate estimations. A large multicenter trial with sufficient power for a complete analysis of possible confounders is warranted to improve the quantification of the event rates and to confirm the differences between the subgroups. In addition, that QRS duration was tested continuously as well as categorically using a predefined cut off may introduce type I statistical error in the current evaluation. However, a consistent association between QRS duration and patient outcome was observed whether QRS duration was entered continuously or categorically in the regression equation. Clinical implications. The current study demonstrates that both QRS duration itself and the changes in QRS duration after PVR can be used to identify patients who are at increased risk for adverse events during follow-up after PVR. Therefore, the patients who have a QRS duration 180 ms either before or after PVR, and the patients who do not demonstrate improvement of QRS duration after PVR, may require a vigilant follow-up regimen, as they exhibit a high risk for adverse outcome. Currently, PVR is recommended when important PR and severe RV dilation occur, specifically when this coincides with reduced NYHA functional class (18,24). As the current study demonstrates that severely prolonged QRS duration ( 180 ms) is associated with increased incidence of adverse outcome, it could be postulated that PVR should be performed before severe QRS prolongation occurs. The latter point, however, needs to be confirmed in a sufficiently powered clinical trial. Conclusions The QRS duration either before or after PVR and the changes in QRS duration after PVR are important determinants of long-term outcome in adults with TOF and may serve as an easy screening tool to identify patients at high risk for adverse events after PVR. Reprint requests and correspondence: Dr. Hubert W. Vliegen, Department of Cardiology, Leiden University Medical Centre, C5-P, P.O. Box 9600, Leiden 2300 RC, the Netherlands. h.w.vliegen@lumc.nl. REFERENCES 1. Oosterhof T, Hazekamp MG, Mulder BJ. Opportunities in pulmonary valve replacement. Expert Rev Cardiovasc Ther 2009;7: Roest AA, Helbing WA, Kunz P, et al. Exercise MR imaging in the assessment of pulmonary regurgitation and biventricular function in patients after tetralogy of Fallot repair. Radiology 2002;223: Norozi K, Buchhorn R, Bartmus D, et al. Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of Fallot is due to biventricular dysfunction as determined by the myocardial performance index. Am J Cardiol 2006;97: Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot. Circulation 2002;106: Adamson L, Vohra HA, Haw MP. Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function? Interact Cardiovasc Thorac Surg 2009;9: Gengsakul A, Harris L, Bradley TJ, et al. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg 2007;32: Graham TP Jr., Bernard Y, Arbogast P, et al. Outcome of pulmonary valve replacements in adults after tetralogy repair: a multi-institutional study. Congenital Heart Dis 2008;3: van Huysduynen BH, van Straten A, Swenne CA, et al. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J 2005;26: Hooft van HB, Henkens IR, Swenne CA, et al. Pulmonary valve replacement in tetralogy of Fallot improves the repolarization. Int J Cardiol 2008;124: Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995;92: Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000;356: Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006;27: van Straten A, Vliegen HW, Hazekamp MG, et al. Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot. Radiology 2004;233: Scherptong RW, Vliegen HW, Winter MM, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation 2009;119: Scherptong RW, Henkens IR, Man SC, et al. Normal limits of the spatial QRS-T angle and ventricular gradient in 12-lead electrocardiograms of young adults: dependence on sex and heart rate. J Electrocardiol 2008;41: Scherptong RW, Mollema SA, Blom NA, et al. Right ventricular peak systolic longitudinal strain is a sensitive marker for right ventricular deterioration in adult patients with tetralogy of Fallot. Int J Cardiovasc Imaging 2009;25: Giardini A, Specchia S, Coutsoumbas G, et al. Impact of pulmonary regurgitation and right ventricular dysfunction on oxygen uptake recovery kinetics in repaired tetralogy of Fallot. Eur J Heart Fail 2006;8: Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol 2000;36: Troost E, Meyns B, Daenen W, et al. Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration. Eur Heart J 2007;28: Fiore AC, Rodefeld M, Turrentine M, et al. Pulmonary valve replacement: a comparison of three biological valves. Ann Thorac Surg 2008;85: Book WM, Parks WJ, Hopkins KL, Hurst JW. Electrocardiographic predictors of right ventricular volume measured by magnetic resonance imaging late after total repair of tetralogy of Fallot. Clin Cardiol 1999;22: Neffke JG, Tulevski II, van der Wall EE, et al. ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters. Heart 2002;88: Budts W, Defoor J, Stevens A, Vanden Wyngaerd M, Moons P, Vanhees L. Changes in QRS duration are associated with maximal exercise capacity in adult patients with repaired tetralogy of Fallot. Int J Cardiol 2005;104: Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007;116: Key Words: electrocardiography y outcome y pulmonary valve replacement y QRS duration y tetralogy of Fallot.
Long-Term Follow-Up after Pulmonary Valve Replacement in Adults with Tetralogy of Fallot: Association between QRS duration and Outcome
Long-Term Follow-Up after Pulmonary Valve Replacement in Adults with Tetralogy of Fallot: Association between QRS duration and Outcome ESC Congress 2010 - Stockholm M.L.A. Haeck 1, R.W.C. Scherptong 1,
More informationSurgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital
Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart
More informationIn patients with corrected tetralogy of Fallot and residual. Pediatric Cardiology
Pediatric Cardiology Preoperative Thresholds for Pulmonary Valve Replacement in Patients With Corrected Tetralogy of Fallot Using Cardiovascular Magnetic Resonance Thomas Oosterhof, MD, PhD; Alexander
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationChapter 5. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume
Chapter 5 Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume Bart Hooft van Huysduynen Alexander van Straten Cees A.
More informationReduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume
European Heart Journal (2005) 26, 928 932 doi:10.1093/eurheartj/ehi140 Clinical research Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of
More informationTetralogy of Fallot is a common form of cyanotic heart
Predicting Outcome of Pulmonary Valve Replacement in Adult Tetralogy of Fallot Patients Ivo R. Henkens, MD, Alexander van Straten, MD, Martin J. Schalij, MD, PhD, Mark G. Hazekamp, MD, PhD, Albert de Roos,
More informationA teenager with tetralogy of fallot becomes a soccer player
ISSN 1507-6164 DOI: 10.12659/AJCR.889440 Received: 2013.06.06 Accepted: 2013.07.10 Published: 2013.09.23 A teenager with tetralogy of fallot becomes a soccer player Authors Contribution: Study Design A
More informationTricuspid valve surgery in patients with a systemic right ventricle
Tricuspid valve surgery in patients with a systemic right ventricle Roderick Scherptong, Hubert Vliegen, Michiel Winter, Barbara Mulder, Ernst van der Wall, Dave Koolbergen, Mark Hazekamp Eduard Holman,
More informationEvaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death
Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death Presenters: Sabrina Phillips, MD FACC FASE Director, Adult Congenital Heart Disease Services The University of Oklahoma
More informationTetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve
Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve Alexandra A Frogoudaki Adult Congenital Heart Clinic Second Cardiology Department ATTIKON University Hospital No
More informationShuichi Shiraishi, Masashi Takahashi, Ai Sugimoto, Masanori Tsuchida. Introduction
Original Article Predictors of ventricular tachyarrhythmia occurring late after intracardiac repair of tetralogy of Fallot: combination of QRS duration change rate and tricuspid regurgitation pressure
More informationResearch Presentation June 23, Nimish Muni Resident Internal Medicine
Research Presentation June 23, 2009 Nimish Muni Resident Internal Medicine Research Question In adult patients with repaired Tetralogy of Fallot, how does Echocardiography compare to MRI in evaluating
More informationMagnetic Resonance Imaging to Assess the Hemodynamic Effects of Pulmonary Valve Replacement in Adults Late After Repair of Tetralogy of Fallot
Magnetic Resonance Imaging to Assess the Hemodynamic Effects of Pulmonary Valve Replacement in Adults Late After Repair of Tetralogy of Fallot Hubert W. Vliegen, MD; Alexander van Straten, MD; Albert de
More informationS. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences
S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences No financial disclosures Aorta Congenital aortic stenosis/insufficiency
More informationThe need for right ventricular outflow tract reconstruction
Polytetrafluoroethylene Bicuspid Pulmonary Valve Implantation James A. Quintessenza, MD The need for right ventricular outflow tract reconstruction and pulmonary valve replacement is increasing for many
More informationJournal of the American College of Cardiology Vol. 60, No. 11, by the American College of Cardiology Foundation ISSN /$36.
Journal of the American College of Cardiology Vol. 60, No. 11, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.03.077
More informationcctga patients need lifelong follow-up in an age-appropriate facility with expertise in
ONLINE SUPPLEMENT ONLY: ISSUES IN THE ADULT WITH CCTGA General cctga patients need lifelong follow-up in an age-appropriate facility with expertise in congenital heart disease care at annual intervals.
More informationPulmonary Valve Replacement
Indications/Timing and Type of Interventions: Pulmonary Valve Replacement Lars Sondergaard, MD, DMSc Professor of Cardiology Rigshospitalet Copenhagen, Denmark Case 15 years old girl with tetralogy of
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement Christian Kreutzer MD Hospital Nacional Alejandro Posadas Hospital Universitario Austral (No disclosures) Scope of the problem. CHD with PS or PA require a RVOT procedure. Tetralogy
More informationejection fraction: RVEF) 45 % 2
2 2 22 28 (2013 ) (TOF) TOF (PVR) 2003 4 2011 6 PVR 15 PVR follow up 4.3 ± 2.4 NYHA class 1 RVEDVI 165.4 ± 51.4 ml/m2 105.9 ± 22.4 ml/m2 RVESVI 91.3 ± 42.6 ml/m2 62.7 ± 18.8 ml/m2 (P < 0.05) QRS 176.4
More informationPediatric Cardiology
Pediatric Cardiology Pulmonary Valve Replacement in Tetralogy of Fallot Impact on Survival and Ventricular Tachycardia David M. Harrild, MD, PhD; Charles I. Berul, MD; Frank Cecchin, MD; Tal Geva, MD;
More informationDebate in CHD - When Should We
Debate in CHD - When Should We Replace Pulmonary Valve? Lee, Jae Young Dept. of Pediatrics, Seoul Saint Mary s Hospital The Catholic University of Korea 14 yr/m, TOF repair (1yr) FC I PR Fraction - 48
More informationFactors Associated With Impaired Clinical Status in Long-Term Survivors of Tetralogy of Fallot Repair Evaluated by Magnetic Resonance Imaging
Journal of the American College of Cardiology Vol. 43, No. 6, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.045
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Cardiovascular magnetic resonance for timing pulmonary valve replacement E.Valsangiacomo Buechel University Children s Hospital Zurich Outline Introduction Pulmonary
More informationCardiac MRI in ACHD What We. ACHD Patients
Cardiac MRI in ACHD What We Have Learned to Apply to ACHD Patients Faris Al Mousily, MBChB, FAAC, FACC Consultant, Pediatric Cardiology, KFSH&RC/Jeddah Adjunct Faculty, Division of Pediatric Cardiology
More informationMRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT
MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT Linda B Haramati MD, MS Departments of Radiology and Medicine Bronx, New York OUTLINE Pathogenesis Variants Initial surgical treatments Basic MR protocols
More informationRVOTO adult and post-op
Right ventricular outflow tract obstruction in the adult: native and post-op Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center University of
More informationPerformance of Bovine Pericardial Valves in the Pulmonary Position
Performance of Bovine Pericardial Valves in the Pulmonary Position Takeshi Shinkawa, MD, Petros V. Anagnostopoulos, MD, Natalie C. Johnson, BS, Naruhito Watanabe, MD, Anil Sapru, MD, and Anthony Azakie,
More informationArrhythmias and congenital heart disease
Arrhythmias and congenital heart disease Jolien Roos-Hesselink ErasmusMC Rotterdam Netherlands Patient W, born in 1969 Tetralogy of Fallot 1975 at the age of 6 years surgical correction 2002 Patient W:
More informationClinical Outcomes of Pulmonary Valve Replacement in Patients Late after Repair of Tetralogy of Fallot
PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 25 NO. 1 (45 52) 1 1 2 2 1 1 3 4 2 1 2 3 4 Clinical Outcomes of Pulmonary Valve Replacement in Patients Late after Repair of Tetralogy of Fallot 1) Jun Muneuchi,
More informationSurgical Management of Chronic Pulmonary Regurgitation After Relief of Right Ventricular Outflow Tract Obstruction
Review Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Surgical Management of Chronic Pulmonary Regurgitation After Relief of Right Ventricular Outflow Tract Obstruction Cheul Lee,
More informationPulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI.
Pulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI. Queen Sirikit National Institute of Child Health (QSNICH) Bangkok, Thailand How to Assess?
More informationPulmonary Valve Replacement Late After Repair of Tetralogy of Fallot
Pulmonary Valve Replacement Late After Repair of Tetralogy of Fallot Ilya M. Yemets, MD, William G. Williams, MD, Gary D. Webb, MD, David A. Harrison, MD, Peter R. McLaughlin, MD, George A. Trusler, MD,
More informationFor Personal Use. Copyright HMP 2013
12-00415 Case Report J INVASIVE CARDIOL 2013;25(4):E69-E71 A Concert in the Heart. Bilateral Melody Valve Implantation in the Branch Pulmonary Arteries Nicola Maschietto, MD, PhD and Ornella Milanesi,
More informationTiming and Technique of Pulmonary Valve Replacement in the Patient With Tetralogy of Fallot
Timing and Technique of Pulmonary Valve Replacement in the Patient With Tetralogy of Fallot James S. Tweddell, a,b Pippa Simpson, c Shun-Hwa Li, c Jennifer Dunham-Ingle, b Peter J. Bartz, b,d Michael G.
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationPercutaneous pulmonary valve replacement after different duration of free pulmonary regurgitation in a porcine model: effects on the right ventricle
Percutaneous pulmonary valve replacement after different duration of free pulmonary regurgitation in a porcine model: effects on the right ventricle Mads Ersboll a, Niels Vejlstrup a, Jens Christian Nilsson
More informationThe pulmonary valve is the most common heart valve
Biologic versus Mechanical Valve Replacement of the Pulmonary Valve After Multiple Reconstructions of the RVOT Tract S. Adil Husain, MD, and John Brown, MD Indiana University School of Medicine, Department
More informationRisk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects
Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the
More informationUse of Cardiac Computed Tomography for Ventricular Volumetry in Late Postoperative Patients with Tetralogy of Fallot
Korean J Thorac Cardiovasc Surg 2017;50:71-77 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.71 Use of Cardiac Computed Tomography for Ventricular
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More informationInstitute of Cardiology Warsaw, Poland
Mateusz Śpiewak, Elżbieta K. Biernacka, Łukasz A. Małek, Jolanta Miśko, Joanna Petryka, Mirosław Kowalski, Barbara Miłosz, Magdalena Żabicka, Piotr Hoffman, Witold Rużyłło Institute of Cardiology Warsaw,
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20556 holds various files of this Leiden University dissertation. Author: Scherptong, Roderick Wiebe Conrad Title: Characterization of the right ventricle
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationSurgery for Congenital Heart Disease. Randomized Trial of Pulmonary Valve Replacement With and Without Right Ventricular Remodeling Surgery
Surgery for Congenital Heart Disease Randomized Trial of Pulmonary Valve Replacement With and Without Right Ventricular Remodeling Surgery Tal Geva, MD; Kimberlee Gauvreau, ScD; Andrew J. Powell, MD; Frank
More informationSurgical Treatment for Double Outlet Right Ventricle. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery
for Double Outlet Right Ventricle Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery 1 History Intraventricular tunnel (Kawashima) First repair of Taussig-Bing anomaly (Kirklin) Taussig-Bing
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationProgressive right ventricular volume overload from
Expanding the Indications for Pulmonary Valve Replacement After Repair of Tetralogy of Fallot Kenneth G. Warner, MD, Patrick K. H. O Brien, MD, Jonathan Rhodes, MD, Avnit Kaur, MD, Davida A. Robinson,
More informationInter-surgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years experience with 675 patients.
Inter-surgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years experience with 675 patients. Y d'udekem, JC Galati, IE Konstantinov, MMH Cheung, CP Brizard Royal
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationM Y Abd El Rahman, H Abdul-Khaliq, M Vogel, V Alexi-Meskishvili, M Gutberlet, P E Lange
416 Congenital Heart Disease, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany M Y Abd El Rahman H Abdul-Khaliq M Vogel P E Lange Cardiac Surgery, Deutsches Herzzentrum Berlin
More informationManagement of Tricuspid Regurgitation
Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationThe incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients
The Turkish Journal of Pediatrics 2008; 50: 549-553 Original The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients Selman Vefa Yıldırım 1, Kürşad
More informationAdults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP
Adults with Congenital Heart Disease Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP Outline History of CHD Statistics Specific lesions (TOF, TGA, Single ventricle) Erythrocytosis Pregnancy History
More informationFailure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict
DOI 10.1007/s12471-011-0158-5 ORIGINAL ARTICLE Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict M. C. Post & W. Budts & A. Van de Bruaene & R. Willems
More informationArrhythmias in Adult Congenital Heart Disease
Arrhythmias in Adult Congenital Heart Disease NAAMA s 24 th International Medical Convention Beirut, Lebanon June 26 July 2, 2010 Naser Ammash, MD Mayo School of Medicine Rochester, Minnesota CP1212391-1
More informationDiagnosis and mortality prediction in pulmonary hypertension: the value of the electrocardiogram-derived ventricular gradient
Available online at www.sciencedirect.com Journal of Electrocardiology 45 (2012) 312 318 www.jecgonline.com Diagnosis and mortality prediction in pulmonary hypertension: the value of the electrocardiogram-derived
More informationADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS
ADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS V.S. Mahadevan, MD, F.R.C.P. Director, Structural and Adult congenital Interventional Cardiology Program William W
More informationScreening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden
Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden m.v.huisman@lumc.nl Background CETPH Chronic Thrombo Embolic Pulmonary Hypertension
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationSurgical options for tetralogy of Fallot
Surgical options for tetralogy of Fallot Serban Stoica FRCS(CTh) MD ACHD study day, 19 September 2017 Anatomy Physiology Children Adults Complications Follow up Anatomy Etienne Fallot (1850-1911) VSD Overriding
More informationImplantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect
The Ochsner Journal 10:27 31, 2010 f Academic Division of Ochsner Clinic Foundation Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect Anas Bitar, MD, Maria Malaya
More informationManagement of Heart Failure in Adult with Congenital Heart Disease
Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form
More informationMini Forum for Pediatric Cardiac Disease in Young Adulthood
Mini Forum for Pediatric Cardiac Disease in Young Adulthood Acta Cardiol Sin 2015;31:478 484 doi: 10.6515/ACS20150210A Assessing Late Cardiopulmonary Function in Patients with Repaired Tetralogy of Fallot
More informationPregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia
Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics
More informationSurgical Repair of Ventricular Septal Defect; Contemporary Results and Risk Factors for a Complicated Course
Pediatr Cardiol (2017) 38:264 270 DOI 10.1007/s00246-016-1508-2 ORIGINAL ARTICLE Surgical Repair of Ventricular Septal Defect; Contemporary Results and Risk Factors for a Complicated Course Maartje Schipper
More informationJournal of Rare Cardiovascular Diseases 2014; 1 (7):
Journal of Rare Cardiovascular Diseases 2014; 1 (7): 24 28 www.jrcd.eu CASE REPORT Rare congenital cardiovascular diseases Female patient after correction of tetralogy of Fallot with severe pulmonary regurgitation
More informationPulmonary valve: Imaging assessment
Pulmonary valve: Imaging assessment Fraisse Royal Brompton and Harefield Hospital London, U.K. Consultant and Proctor for medtronic Potential consequences of pulmonary valve Dysfunction RV obstruction
More informationCOMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?
COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE? Aurora S. Gamponia, MD, FPPS, FPCC, FPSE OBJECTIVES Identify complex congenital heart disease at high risk or too late for intervention
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/37621 holds various files of this Leiden University dissertation Author: Sum-Che Man Title: Vectorcardiographic diagnostic & prognostic information derived
More informationWhen blue babies grow up: What you need to know about tetralogy of Fallot
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will recognize the early signs and symptoms of pulmonary insufficiency in adult patients with tetralogy of Fallot David Fox, ME, PA-C Department of Cardiovascular
More informationSince first successfully performed by Jatene et al, the
Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,
More informationAssessing the Impact on the Right Ventricle
Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal
More informationWhen to implant an ICD in systemic right ventricle?
When to implant an ICD in systemic right ventricle? Département de rythmologie et de stimulation cardiaque Nicolas Combes n.combes@clinique-pasteur.com Pôle de cardiologie pédiatrique et congénitale Risk
More informationPulmonary regurgitation: not a benign lesion
European Heart Journal (2005) 26, 433 439 doi:10.1093/eurheartj/ehi091 Review Pulmonary regurgitation: not a benign lesion Beatriz Bouzas 1,2, Philip J. Kilner 2, and Michael A. Gatzoulis 1 * 1 Adult Congenital
More informationCME. Original Research
CME JOURNAL OF MAGNETIC RESONANCE IMAGING 38:829 835 (2013) Original Research Interstudy Variability in Cardiac Magnetic Resonance Imaging Measurements of Ventricular Volume, Mass, and Ejection Fraction
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationComplex Congenital Heart Disease in Adults
Complex Congenital Heart Disease in Adults Linda B. Haramati, MD Disclosures Complex Congenital Heart Disease in Adults Linda B. Haramati MD, MS Jeffrey M. Levsky MD, PhD Meir Scheinfeld MD, PhD Department
More informationIn 1980, Bex and associates 1 first introduced the initial
Technique of Aortic Translocation for the Management of Transposition of the Great Arteries with a Ventricular Septal Defect and Pulmonary Stenosis Victor O. Morell, MD, and Peter D. Wearden, MD, PhD In
More informationOriginal Policy Date
MP 7.01.111 Transcatheter Pulmonary Valve Implantation Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return to
More informationORIGINAL RESEARCH. Downloaded from by on April 4, 2019
Whether Pulmonary Valve Replacement in Asymptomatic Patients With Moderate or Severe Regurgitation After Tetralogy of Fallot Repair Is Appropriate: A Case-Control Study Fengpu He, MD, PhD;* Zicong Feng,
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationAdult Congenital Heart Disease T S U N ` A M I!
Adult Congenital Heart Disease T S U N ` A M I! Erwin Oechslin, MD, FRCPC, FESC Director, Congenital Cardiac Centre for Adults University Health Network Peter Munk Cardiac Centre / Toronto General Hospital
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationPeak Oxygen Uptake, Ventilatory Efficiency and QRS-Duration Predict Event Free Survival in Patients late after Surgical Repair of Tetralogy of Fallot
Accepted Manuscript Peak Oxygen Uptake, Ventilatory Efficiency and QRS-Duration Predict Event Free Survival in Patients late after Surgical Repair of Tetralogy of Fallot Jan Müller, Alfred Hager, Gerhard-Paul
More informationPatients with congenital heart defects such as tetralogy of Fallot (TOF) may
Surgery for Congenital Heart Disease Harris et al Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease Matthew A. Harris,
More informationLate Results after Correction of Ventricular Septal Defect with Severe Pulmonary Hypertension
Tohoku J. Exp. Med., 1994, 174, 41-48 Late Results after Correction of Ventricular Septal Defect with Severe Pulmonary Hypertension KIYOSHI HANEDA, NAOSHI SATO, TAKAO TOGO, MAKOTO MIURA, MASAKI RATA and
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationA Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE
A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE Adele Greyling Dora Nginza Hospital, Port Elizabeth SA Heart November 2017 What are the guidelines based on? MADIT-II Size:
More informationManagement of complex CHD in adults
Management of complex CHD in adults Victor Tsang Society of Thoracic Surgeons of Thailand 2016 The impact of infant cardiac surgery Over 90 % of infants born with CHD will reach adulthood By 2010, adults
More informationCASE REPORT. Case Report
CASE REPORT Regular Treatment Strategy with a Large Amount of for Heart Failure Improves Biventricular Systolic Failure in a Patient with Repaired Tetralogy of Fallot Katsura Soma, 1 MD, Atsushi Yao, 2
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous pulmonary valve implantation for right ventricular outflow tract
More information